Frazier Healthcare Partners
Facts
- HQ
- Seattle, WA, US
- Sectors
- Venture Capital and Private Equity Principals
- Founded
- 1991
- Employees
- 168
Generative AI Poised to Boost Healthcare Efficiency but Slow Adoption and Sales Cycles Challenge Startups, Says Frazier’s Nader Naini
Generative AI and automation offer efficiency opportunities in the $4.5 trillion healthcare sector, but startups face challenges due to slow technology adoption and lengthy sales cycles. Venture funding in digital health exceeded $10 billion last year, with strong activity in Seattle-area startups and increased M&A.
Frazier Healthcare Partners Raises $2.3 Billion for 11th Buyout Fund to Invest in Middle-Market Healthcare Firms
Seattle-based Frazier Healthcare Partners raised $2.3 billion for its 11th Healthcare Growth Buyout Fund, significantly surpassing its previous $1.4 billion fund. The firm plans to use the capital to acquire controlling stakes in about 10 middle-market healthcare companies across pharmaceutical services, hospital outsourcing, and data analytics/AI sectors.
Alpine Immune Sciences raises $91M in private placement led by Frazier to fund ALPN-303 phase 1 and ALPN-202 cancer trials
Alpine Immune Sciences raised about $91 million via a private placement led by Frazier Healthcare Partners to advance ALPN-303 into a phase 1 study for lupus and other inflammatory diseases and to support ongoing cancer trials of ALPN-202, including a combination study with Merck's Keytruda.
People
-
Nader Naini Managing Partner
